The UKRI Strategy 2026–2031 sets a clearer direction for how public research funding will connect with commercialisation, private investment and UK economic growth. For universities, spin-outs and technology businesses, the implication is straightforward: excellent research remains essential, but stronger commercial evidence will be expected much earlier.
The strategy sets out three broad priorities: supporting discovery-led research, addressing national and societal challenges, and helping innovative companies start, scale and remain in the UK.
This represents more than a change in funding terminology. UKRI is signalling a shift towards a more connected innovation system, where research, commercialisation, private investment and economic growth are considered together.
For deep-tech innovators, this creates significant opportunities. It also raises the standard.
What changes under the UKRI Strategy 2026–2031?
The UK is highly effective at producing research, intellectual property and university spin-outs. Its persistent weakness is converting enough of those assets into large, sustainable companies.
Technologies often become trapped between research funding and commercial adoption. A project may complete a successful technical programme but still lack a clearly defined customer, a scalable manufacturing route, an investable management team or the evidence required for procurement.
UKRI’s new strategy recognises this problem directly.
It intends to provide more connected support across research, finance, regulation, market development and business scale-up. It also plans to identify high-potential companies earlier and support them through critical stages of development rather than relying entirely on isolated grants.
This direction is broadly sensible. Commercialisation does not happen through a simple linear sequence.
Customer discovery can alter the product. Regulation can change the route to market. Manufacturing costs can undermine an otherwise successful prototype. Investor requirements can expose weaknesses that were never considered during the original research programme.
The question is whether UKRI can translate the strategy into genuinely joined-up support without adding another administrative layer.
Funding is likely to become more selective
The strategy should not be interpreted as a promise of more support for every project.
UKRI intends to target resources towards businesses and technologies with the strongest potential for transformation, scale and national benefit. It also wants a larger proportion of supported companies to attract private equity or venture capital.
This means technical novelty alone will not be enough.
Competitive projects will increasingly need to demonstrate:
- A clearly defined and commercially important customer problem
- Evidence that customers or industrial partners will adopt the solution
- A credible route from prototype to manufacture and deployment
- Defensible intellectual property or another meaningful competitive advantage
- A management team capable of delivering commercial growth
- Realistic capital requirements
- A route to private investment, revenue or procurement
- Economic value that can be retained in the UK
This does not reduce the importance of good science and engineering. It means that technical excellence must be connected to a credible commercial proposition.
A generic market report added shortly before a grant deadline will not be sufficient.
Public funding will need to unlock private capital
One of the most important features of the strategy is the emphasis on investment leverage.
UKRI wants public funding to attract additional private capital across its major programmes. This will increase scrutiny of what happens after the funded project ends.
Applicants will need to explain not only how they will complete the technical work, but how the resulting evidence will unlock the next stage.
That could involve:
- Customer-funded demonstrations
- Corporate investment
- Equity finance
- Licensing agreements
- Procurement commitments
- Joint ventures
- Manufacturing partnerships
- Follow-on industrial research
The strongest proposals will set out the sequence clearly.
What evidence will the project create? Who needs to see that evidence? What commercial or investment decision will it enable? How much additional capital may be required, and from where?
Public funding should not be presented as a substitute for customer demand. It should be used to remove a specific technical, regulatory, manufacturing or investment barrier that the private sector cannot reasonably address alone.
The priority sectors strongly favour deep tech
The strategy identifies substantial investment across areas including artificial intelligence, digital infrastructure, advanced manufacturing and clean energy.
It also gives prominence to technologies such as:
- Robotics and intelligent automation
- Batteries and energy storage
- Advanced materials
- Power electronics
- Semiconductors
- Engineering biology
- Quantum technologies
- Digital manufacturing
- Clean-energy systems
This aligns well with many of the UK’s strongest research and industrial capabilities.
However, strategic alignment should not be confused with automatic funding eligibility.
A project does not become competitive simply because it includes AI, batteries, robotics or clean energy. It must demonstrate why the problem matters, why the proposed intervention is needed and why the UK has a credible opportunity to lead.
Broad market-growth figures will not be enough. Applicants will need sector-specific evidence and a clear understanding of where the technology sits within the relevant value chain.
UK intellectual property must create UK value
The strategy also places greater emphasis on retaining the economic value created from publicly supported research.
This is particularly relevant for spin-outs and deep-tech businesses pursuing international markets.
Many UK technologies need overseas customers, investors, demonstration sites and manufacturing partners to scale. International expansion is not the problem. The issue is whether the commercial structure strengthens or weakens the UK business.
Companies should be able to explain:
- Where the intellectual property will be owned
- Where core research and engineering will take place
- Where high-value jobs will be created
- How international subsidiaries or partnerships will benefit the UK company
- Whether manufacturing capability can be retained or developed domestically
- How overseas investment will support, rather than displace, UK operations
This is especially important for companies seeking US market access.
A US subsidiary, customer trial or manufacturing partnership can support UK growth, provided the underlying IP remains protected and the value generated flows back into the UK business.
The commercial structure needs to be designed deliberately. It should not be left until an investor, university or public funder raises concerns.
Regional impact will face greater scrutiny
Place-based growth is another clear theme.
Projects will increasingly be expected to demonstrate benefits beyond an individual research institution or local cluster.
For organisations based in Oxford, Cambridge or London, reputation alone will not constitute a sufficient economic-impact case.
A strong proposal should show how the technology could contribute to:
- UK supply chains
- Manufacturing deployment
- Regional jobs
- Productivity improvements
- Export income
- Industrial adoption
- Collaboration across different regions
- New technical or production capability
A project can be led from Oxford and still create significant national value. But that value must be evidenced rather than assumed.
What innovators should do now
The detailed structure of future UKRI programmes will continue to develop. Organisations should not wait for each funding competition to open before preparing.
There are five practical actions that research teams and companies should take now.
1. Validate the customer problem early
Speak to customers, operators, regulators, manufacturers and procurement teams before the project scope is fixed.
The objective is not to collect supportive quotations. It is to test whether the proposed technology solves a problem that is important enough to justify adoption.
2. Build the investment pathway into the project
Identify the capital needed after the public funding ends.
Define what evidence an investor, customer or strategic partner will require before committing that capital.
3. Resolve intellectual-property ownership
Clarify who owns the background IP, who will own project-generated IP and how the technology will be licensed or transferred into a company.
Unresolved ownership can delay company formation and block investment at a critical stage.
4. Quantify UK economic value
Avoid vague statements about jobs, exports or productivity.
Explain which capabilities will be created, where they will sit and how the project will generate value for the UK economy.
5. Design the project around a commercial decision
A successful programme should enable a defined next step.
That could be a customer pilot, procurement decision, licence agreement, investment round or manufacturing commitment.
If the project ends with only a technical report, the commercial pathway is probably underdeveloped.
A stronger system, provided delivery matches the ambition
The UKRI 2026–2031 strategy addresses a longstanding weakness in UK innovation: strong research does not automatically produce strong companies.
Its proposed response is more selective investment, stronger commercial support, greater private-capital leverage and a clearer focus on retaining intellectual property and economic value in the UK.
The direction is broadly right.
The risk is that commercialisation becomes another application requirement rather than a disciplined process of testing markets, building products and securing investment.
The difference will be execution.
At Hatch Oxford, we work with universities, spin-outs and deep-tech businesses to convert technical innovation into evidence-backed commercial propositions. Our work includes customer validation, business-model development, consortium formation, intellectual-property planning, investor readiness and international market development.
The organisations best placed to benefit from the next generation of UKRI programmes will be those that start preparing before the calls open. They will not simply have promising technology. They will be able to show where it fits, who needs it, how it will scale and why its success will create lasting value for the UK.
